Clinical trial
Medtronic CoreValve™ Evolut™ PRO System China Clinical Study
NCT04982588 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Medtronic CoreValve™ Evolut™ PRO System China Clinical Study
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 17, 2021
- Completion date
- May 15, 2028
- Enrollment
- 52 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
severe, symptomatic aortic stenosis